HOPE Center News

Congrats to Dr. Bhattacharjee!

HOPE Center investigators Daniel Malone, RPH, PhD, FAMCP, and Amy Grizzle, PharmD, recently published a new study assessing methods used to find evidence about potential drug-drug interactions (PDDIs).

HOPE Center doctoral students and faculty collaborate in this new cost-effectiveness study.

Insight from Dr. Khalid Eljaaly, a post-doctoral fellow alumni.

Health and Pharmaceutical Outcomes graduate student, Srujitha Marupuru, PharmD presented her research at the 2018 ACCP Global Conference.

Though there are currently only 12 biosimilars approved by the Food and Drug Administration (FDA), there are many more in the pipeline, and the oncology world is bracing itself for their impact. How will they be incorporated into practice? What will it mean for the health care ecosystem?

UA students were introduced to the principles and applications of health outcomes research, and discussed related career tracks in the pharmaceutical industry, academia, and managed care.

Dr. Hurwitz led the group through developing and analyzing a decision model.

Dr. Malone outlined the U.S. value frameworks and their implications for decision-making at the ISPOR Dubai 2018 Conference.

Honorary research fellows for the HOPE Center received high-profile recognition for recent work.

The algorithms will be incorporated into electronic health record systems to alert providers about relevant, patient-specific, potential drug interactions.

Ivo Abraham, PhD, RN, previously served as the Quantitate Methods Associate Editor.

We need more awareness of the necessity of depression screening among adults.

The Center for Health Outcomes & PharmacoEconomic Research completed their 6th annual meta-analysis training program!